Business Description
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US92407M2061
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.91 | |||||
| Equity-to-Asset | -0.38 | |||||
| Debt-to-Equity | -1.21 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -120.05 | |||||
| Beneish M-Score | -4.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 8.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 8.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.13 | |||||
| 9-Day RSI | 49.72 | |||||
| 14-Day RSI | 47.85 | |||||
| 6-1 Month Momentum % | -21.98 | |||||
| 12-1 Month Momentum % | -23.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.03 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.51 | |||||
| Days Inventory | 26.63 | |||||
| Days Sales Outstanding | 59.7 | |||||
| Days Payable | 102.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.1 | |||||
| Shareholder Yield % | 1.45 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.54 | |||||
| Operating Margin % | -200.36 | |||||
| Net Margin % | -176.74 | |||||
| FCF Margin % | -174.06 | |||||
| ROE % | -1901.62 | |||||
| ROA % | -157.04 | |||||
| ROIC % | -944.93 | |||||
| ROC (Joel Greenblatt) % | -2748.13 | |||||
| ROCE % | -375.53 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.3 | |||||
| EV-to-EBIT | -2.25 | |||||
| EV-to-EBITDA | -2.28 | |||||
| EV-to-Revenue | 4.51 | |||||
| EV-to-Forward-Revenue | 2.6 | |||||
| EV-to-FCF | -2.6 | |||||
| Price-to-Median-PS-Value | 0.14 | |||||
| Earnings Yield (Greenblatt) % | -44.44 | |||||
| FCF Yield % | -38.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.492 | ||
| EPS (TTM) (€) | -1.638 | ||
| Beta | 1.32 | ||
| Volatility % | 23.05 | ||
| 14-Day RSI | 47.85 | ||
| 14-Day ATR (€) | 0.092979 | ||
| 20-Day SMA (€) | 2.889 | ||
| 12-1 Month Momentum % | -23.67 | ||
| 52-Week Range (€) | 2.34 - 4.8 | ||
| Shares Outstanding (Mil) | 12.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Womens Health Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(FRA:CUL)'s stock price today?
The current price of FRA:CUL is €3.04. The 52 week high of FRA:CUL is €4.80 and 52 week low is €2.34.
When is next earnings date of Aspira Womens Health Inc(FRA:CUL)?
The next earnings date of Aspira Womens Health Inc(FRA:CUL) is 2024-05-10 Est..
Does Aspira Womens Health Inc(FRA:CUL) pay dividends? If so, how much?
Aspira Womens Health Inc(FRA:CUL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers